|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
August 14, 2024
CalmWave appointed Andrew Thompson to the company's Board of Advisors. Thompson is a Silicon Valley-based executive, entrepreneur, and investor. From 2003 to 2020, he was co-founder, chief executive, and board member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company's digital medicine solutions improved clinical outcomes delivered by oral drugs. From 1994 to 1999, he was co-founder, chief executive, and board member of FemRx, a provider of solutions for women's health. From 1991 to 1993, he was co-founder and chief financial officer of CardioRhythm, providing minimally invasive arrhythmia surgery, acquired by Medtronic. From 1992 to 1995, he was chairman of the board at Kistler Morse, leading a turn-around and sale of the company to Danaher. Thompson is a named inventor on over 50 patents. He received master's degrees in engineering from Cambridge and education and business from Stanford. Seattle-based CalmWave deploys state-of-the art digital technology and provides clinicians with a holistic view of the information with which to make informed decisions regarding alarm management and patient care.